BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes
BET蛋白抑制剂apabetalone(RVX-208)可抑制心血管疾病和2型糖尿病患者单核细胞的促炎性过度活化。
期刊:Clinical Epigenetics
影响因子:4.4
doi:10.1186/s13148-020-00943-0
Wasiak, Sylwia; Dzobo, Kim E; Rakai, Brooke D; Kaiser, Yannick; Versloot, Miranda; Bahjat, Mahnoush; Stotz, Stephanie C; Fu, Li; Sweeney, Michael; Johansson, Jan O; Wong, Norman C W; Stroes, Erik S G; Kroon, Jeffrey; Kulikowski, Ewelina